Time to treatment for new patients with rheumatoid arthritis in a major metropolitan city

Journal of Rheumatology

Volumn 38, Issue 7, 2011, Pages 1282-1288

  Jamal, Shahin ^a   Alibhai, Shabbir M H ^b   Badley, Elizabeth M ^b   Bombardier, Claire ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Access to care; Early treatment; Health accessibility; Quality of care; Rheumatoid arthritis

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG;

ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; COMORBIDITY; CONTROLLED STUDY; DRUG INDICATION; FEMALE; HUMAN; JOINT SWELLING; MALE; ONSET AGE; PATIENT EDUCATION; PATIENT REFERRAL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; RISK FACTOR; SEX DIFFERENCE; THERAPY; THERAPY DELAY; TIME TO TREATMENT;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; COHORT STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ONTARIO; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; SPECIALIZATION; TIME FACTORS; URBAN HEALTH SERVICES;

EID: 79959965091     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.101315     Document Type: Article

References (37)

1. Van der Heijde DM. Joint erosions and patients with early rheumatoid arthritis. Br J Rheumatol 1995;34 Suppl 2:74-8. (Pubitemid 26013493)
2. Fuchs HA, Kaye JJ, Callahan LF, Nance EP, Pincus T. Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease. J Rheumatol 1989;16:585-91. (Pubitemid 19154397)
3. Tsakonas E, Fitzgerald AA, Fitzcharles MA, Cividino A, Thorne JC, M'Seffar A, et al. Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the Hydroxychloroquine in Early Rheumatoid Arthritis (HERA) study. J Rheumatol 2000;27:623-9. (Pubitemid 30151337)
4. Anderson JJ, Wells G, Verhoeven AC, Felson DT. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum 2000;43:22-9. (Pubitemid 30368209)
5. Mottonen T, Hannonen P, Korpela M, Nissila M, Kautiainen H, Ilonen J, et al. Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum 2002;46:894-8. (Pubitemid 34303799)
6. O'Dell JR, Paulsen G, Haire CE, Blakely K, Palmer W, Wees S, et al. Treatment of early seropositive rheumatoid arthritis with minocycline: four-year followup of a double-blind, placebo-controlled trial. Arthritis Rheum 1999;42:1691-5. (Pubitemid 30263638)
7. Egsmose C, Lund B, Borg G, Pettersson H, Berg E, Brodin U, et al. Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study. J Rheumatol 1995;22:2208-13.
8. Nell VP, Machold KP, Eberl G, Stamm TA, Uffmann M, Smolen JS. Benefit of very early referral and very early therapy with disease-modifying antirheumatic drugs in patients with early rheumatoid arthritis. Rheumatology 2004;43:906-14. (Pubitemid 38996967)
9. Lard LR, Visser H, Speyer I, vander Horst-Bruinsma IE, Zwinderman AH, Breedveld FC, et al. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 2001;111:446-51. (Pubitemid 33016415)
10. Buckland-Wright JC, Clarke GS, Chikanza IC, Grahame R. Quantitative microfocal radiography detects changes in erosion area in patients with early rheumatoid arthritis treated with myocrisine. J Rheumatol 1993;20:243-7. (Pubitemid 23066032)
11. Van der Linden MP, le Cessie S, Raza K, van der Woude D, Knevel R, Huizinga TW, et al. Long-term impact of delay in assessment of patients with early arthritis. Arthritis Rheum 2010;62:3537-46.
12. Finckh A, Liang MH, van Herckenrode CM, de Pablo P. Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta-analysis. Arthritis Rheum 2006;55:864-72. (Pubitemid 44917458)
13. Quinn MA, Conaghan PG, Emery P. The therapeutic approach of early intervention for rheumatoid arthritis: What is the evidence? Rheumatology 2001;40:1211-20.
14. Hochberg MC. Early aggressive DMARD therapy: the key to slowing disease progression in rheumatoid arthritis. Scand J Rheumatol Suppl 1999;112:3-7. (Pubitemid 30032193)
15. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis. 2002. [Internet. Accessed March 11, 2011.]Available from: http://www.rheumatology.org/ practice/clinical/guidelines/raguidelines02.pdf
16. Bykerk VP, Keystone EC. What are the goals and principles of management in the early treatment of rheumatoid arthritis? Best Pract Res Clin Rheumatol 2005;19:147-61.
17. Quinn MA, Emery P. Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention. Clin Exp Rheumatol 2003;5 Suppl 31:S154-7.
18. O'Dell JR. How is it best to treat early rheumatoid arthritis patients? Best Pract Res Clin Rheumatol 2001;15:125-37.
19. O'Dell JR. Therapeutic strategies for rheumatoid arthritis. N Engl J Med 2004;350:2591-602.
20. Potter T, Mulherin D, Pugh M. Early intervention with disease-modifying therapy for rheumatoid arthritis: where do the delays occur? Rheumatology 2002;41:953-5.
21. Gray M, Nuki J. Audit of delay between symptom onset and commencement of disease modifying anti-rheumatic drugs (DMARDs) in patients with newly diagnosed rheumatoid arthritis referred to a hospital rheumatology unit. Rheumatology 2001;40 Suppl 1:60.
22. Jeyaratnam R, Kerr LD, Spiera H, Crane RP, Pugh MT. A comparative analysis of the time taken from onset of symptoms of rheumatoid arthritis to initiation of disease modifying antirheumatic drugs at Mount Sinai Hospital, USA and the Birmingham Heartlands Hospital, UK [abstract]. Rheumatology 2001;40 Suppl 1:29.
23. Irvine S, Munro R, Porter D. Early referral, diagnosis, and treatment of rheumatoid arthritis: evidence for changing medical practice. Ann Rheum Dis 1999;58:510-3. (Pubitemid 29359497)
24. Quinn MA, Emery P. Are early arthritis clinics necessary? Best Pract Res Clin Rheumatol 2005;19:1-17.
25. Cush JJ. Remodeling a rheumatology practice to facilitate early referral. Rheum Dis Clin North Am 2005;31:591-604. (Pubitemid 41608444)
26. Lacaille D, Anis AH, Guh DP, Esdaile JM. Gaps in care for rheumatoid arthritis: a population study. Arthritis Rheum 2005;53:241-8. (Pubitemid 40530165)
27. Glazier RH, Dalby DM, Badley EM, Hawker GA, Bell MJ, Buchbinder R, et al. Management of the early and late presentations of rheumatoid arthritis: a survey of Ontario primary care physicians. CMAJ 1996;155:679-87. (Pubitemid 26336233)
28. Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN. The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum 2003;49:156-63. (Pubitemid 36418272)
29. Goekoop-Ruiterman YP, Vries-Bouwstra JK, Allaart CF, Van Zeben D, Kerstens PJ, Hazes JM, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 2005;52:3381-90. (Pubitemid 41612204)
30. Sokka T, Pincus T. First visit to a rheumatologist of US patients with early rheumatoid arthritis occurs after a median of 5 months of symptoms [abstract]. Arthritis Rheum 2002;46 Suppl:S543.
31. Reed M, Moran H, McColl G, Stockman A, Barraclough D, Van Doornum S, et al. Time to institution of DMARD therapy in Victoria - an early RA pilot study. Intern Med J 2005;35:A112.
32. Chan KW, Felson DT, Yood RA, Walker AM. The lag time between onset of symptoms and diagnosis of rheumatoid arthritis. Arthritis Rheum 1994;37:814-20. (Pubitemid 24184530)
33. Hernandez-Garcia C, Vargas E, Abasolo L, Lajas C, Bellajdell B, Morado IC, et al. Lag time between onset of symptoms and access to rheumatology care and DMARD therapy in a cohort of patients with rheumatoid arthritis. J Rheumatol 2000;27:2323-8.
34. Cho KJ, Jang SH, Lee SK, Doh WS. Utilization characteristics of health care service for rheumatoid arthritis patients in Korea. Yonsei Med J 1998;39:247-51. (Pubitemid 128506880)
35. Sinclair D, Hull RG. Why do general practitioners request rheumatoid factor? A study of symptoms, requesting patterns and patient outcome. Ann Clin Biochem 2003;40 Part 2:131-7. (Pubitemid 36359863)
36. Lard LR, Huizinga TW, Hazes JM, Vlieland TP. Delayed referral of female patients with rheumatoid arthritis. J Rheumatol 2001;28:2190-2. (Pubitemid 32947860)
37. Palm O, Purinszky E. Women with early rheumatoid arthritis are referred later than men. Ann Rheum Dis 2005;64:1227-8. (Pubitemid 41113364)